1、Family Planning Market ReportDECEMBER 2025CONTENTSACKNOWLEDGMENTS 3ACRONYMS 4INTRODUCTION 5EXECUTIVE SUMMARY 8SUPPLIER SHIPMENT ANALYSIS 9UNFPA AND USAID PROCUREMENT VALUE ANALYSIS 25DOMESTIC GOVERNMENT SPEND ANALYSIS 29HIGHLIGHTS FROM DISCUSSIONS WITH KEY STAKEHOLDERS 31CONCLUDING REMARKS 33ABOUT P
2、ARTICIPATING SUPPLIERS 34APPENDICES 363ACKNOWLEDGMENTS1 While the report identifies Senador Laboratories as the data contributing supplier,the volumes attributed to Senador also incorporate historical volumes from Mylan(until November 2020)and Viatris(November 2020October 2023),which owned and opera
3、ted this FP/SRH business prior to Senador Labs.2 Launched in 2019 under the RHSC,the VAN is a collaborative supply chain management network that allows the community to collectively estimate and prioritize supply needs,act when supply imbalances loom,and govern data sharing and use:https:/www.rhsupp
4、lies.org/gfpvan/The Clinton Health Access Initiative(CHAI)and the Reproductive Health Supplies Coalition(RHSC)published the first Family Planning Market Report in 2015 as part of the FP2020 Global Markets Visibility Project.It initially covered 69 FP2020 focus countries and in 2021,it expanded under
5、 the FP2030 global partnership and measurement structure to include all low-and lower-middle income countries,and now reports on 85 countries.Whereas the 2015 report featured data from 11 suppliers,the 2025 edition has 18 participating suppliers.Suppliers shipment data is the foundation of this repo
6、rts analyses,allowing CHAI and RHSC to address information gaps and construct a comprehensive view of the reproductive health commodities market.We would like to thank current participating suppliers:Bayer,Cipla,Corporate Channels,CR Zizhu,Cupid,Female Health Company,Incepta,Injeflex,Medicines360,Or